Sunday, November 29, 2020

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore The volunteer is falsely laying the blame for his medical problems on the trial of COVID-19 vaccine Covishield, said Serum Institute of India

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-vaccine-|-sii-rejects-claimscovishield39s-adverse-effect-threatens-to-seek-damagesexcessrs-100-crore_14538241.html
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Asian shares start cautiously, dollar edges down

Asian shares opened cautiously amid anticipation of fresh trade news influencing US asset demand. The dollar weakened as trade tensions and ...